Aural Analytics‘ speech analytics software app for amyotrophic lateral sclerosis (ALS), intended for use by researchers and doctors working in the disease, has been designated a breakthrough device by the U.S. Food and Drug Administration (FDA).
- image by freepik
![Speech Vitals, software app for ALS research and care, gains FDA support](https://ik.imagekit.io/liricare/kotqbgavop8v7vknxr4p2iab0gd6?response-content-disposition=inline; filename="crop-doctor-using-smarthone-office.jpg"; filename*=UTF-8''crop-doctor-using-smarthone-office.jpg&response-content-type=image/jpeg&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=DO00R3ZGMZZ4HZHQP9YG/20230926/unused/s3/aws4_request&X-Amz-Date=20230926T121909Z&X-Amz-Expires=300&X-Amz-SignedHeaders=host&X-Amz-Signature=a867dfa1303676f41d798d3ac52a534cc5134cb4541619e5e6cbe8558b4da4a0)
alsnewstoday.com
Speech Vitals, software app for ALS research and care, gains FDA support